Sign in

CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company

Actinium Pharmaceuticals, Inc.

Sign in to watch
Ticker
ATNM
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880378336
Phone
(646) 677-3870
Business address
100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
Former names
Cactus Ventures, Inc.
  1. DEF 14A Proxy Proxy Statement
  2. 10-Q Report Quarterly Report
  3. PRE 14A Proxy Proxy Statement (Preliminary)
  4. 424B3 Offering Prospectus
  5. 424B3 Offering Prospectus
  6. EFFECT Other Notice of Effectiveness
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. S-3/A Offering Registration Statement
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. UPLOAD Other SEC-generated Letter
  13. SC 13G Stake Amended Statement of Ownership
  14. 4 Open-market buy Chairman & CEO bought 33,333 shares at $0.75 ($25,000)
  15. 4 Open-market buy Executive Vice President bought 10,000 shares at $0.75 ($7,500)
  16. 10-Q Report Quarterly Report
  17. 424B5 Offering Prospectus
  18. 8-K Event Material agreement · Regulation FD disclosure
  19. 424B5 Offering Prospectus
  20. 8-K Event Material agreement

Page 13 of 26 · 511 filings